Go Pro
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel Free THAT Stock Alerts
LON:THAT

Thalia Therapeutics (THAT) Share Price, News & Analysis

GBX 0.61 -0.01 (-1.92%)
As of 07:14 AM Eastern

About Thalia Therapeutics Stock (LON:THAT)

Key Stats

Today's Range
0.61
▼
0.65
50-Day Range
N/A
52-Week Range
0.40
▼
0.95
Volume
443,238 shs
Average Volume
1.36 million shs
Market Capitalization
£10.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Thalia Therapeutics plc is a pre-clinical biotech company focused on developing innovative RNA therapeutics and novel delivery systems to address high unmet needs in global healthcare. RNA therapeutics is one of the most rapidly growing therapeutic sectors that is set to impact the treatment of a wide range of diseases. Thalia Therapeutics is developing a wholly owned pipeline of novel RNA therapeutics for cardiovascular and other diseases, as well as developing Nuvec®, its proprietary gene delivery system, to further differentiate its therapeutic assets. Nuvec® addresses multiple challenges associated with RNA therapeutics manufacturing and delivery, including the ability to deliver multiple RNA therapies in a single particle, ease of manufacturing, protection of the RNA payload to allow for oral delivery, no unwanted immune response and excellent stability and storage. For further information visit www.thaliatx.com

Receive THAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thalia Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THAT Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

THAT Stock Analysis - Frequently Asked Questions

Thalia Therapeutics (LON:THAT) announced its quarterly earnings data on Wednesday, September, 30th. The company reported ($0.09) earnings per share (EPS) for the quarter.

Shares of THAT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Today
9/30/2026
Last Earnings
9/30/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
LON:THAT
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
£7.26 thousand
Price / Sales
1,498.51
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,775,721,000
Free Float
N/A
Market Cap
£10.89 million
Optionable
N/A
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover
10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (LON:THAT) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners
Dr. Ron Paul Issues New Warning: “The Next Financial Crisis Is Here”
Dr. Ron Paul warns a dangerous experiment is already underway in Washington, involving at least 27 billion dol...
Altimetry | Sponsoredtc pixel
A Little Known Explorer Sits Near Major Gold Deposits
Barrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...
Wall Street Logic | Sponsoredtc pixel
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump Wants to Reprice America's Gold at Market Value
The US government still values its gold reserves at 42 dollars an ounce, a price Congress set in 1973. Gold tr...
Concord Gold Capital | Sponsoredtc pixel
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel